A Case of Autoimmune Pulmonary Alveolar Proteinosis
Chemotherapeutic agents or regular doses of Rituximab may represent a potential therapeutic option for refractory cases of autoimmune pulmonary alveolar proteinosis.
Authors
- Syeda Hafsa Qadri (ORCID: https://orcid.org/0000-0002-4220-4218)
- Nancy M. Hardy (ORCID: https://orcid.org/0000-0002-6054-6836)
- Meher Binte Ali (ORCID: https://orcid.org/0000-0002-1263-6570)
- Yilin Song (ORCID: https://orcid.org/0009-0007-6027-6235)
- Danish Jilani
Institutions
- University of Maryland, Baltimore (US)
- University of Maryland Medical Center (US)
- Dow University of Health Sciences (PK)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/ccr3.72040
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00